Urovant Sciences Ltd. UROV

Set alert

Price alert · UROV

All alert types
— — —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
531.75M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-3.09
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2021
50-d avg
16.21
200-d avg
13.98
1y target
16.17

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for UROV has not been loaded yet. Try again in a moment.

Discussion (1)

Sign in to join the discussion

SUN UROV 5 years ago #1

History $IBIO was built for pandemic purposes in 2010 by DARPA. In 2011 the influenza disease outbreak happened and IBIO hit their peak as a company. Then the disease died out and so did their stock price. In 2014, the outbreak of Ebola happened and so they hit another peak. Now look where we’re at now.Covid is destroying the world in many ways and people are seeing how big this has effected the world so far. IBIO was built for this exact reason. In my opinion, influenza became less dangerous as scientists have developed vaccines and the spread of Ebola died out. COVID will not die for months/years to come. $IBIO shares price in past pandemics 15$-55$, $IBIO is known for FastPharming has applications far beyond producing a COVID-19 vaccine. An example of this potential was a deal signed in October with Safi Biosolutions. The agreement will see iBio’s FastPharming system used in the bioprocessing of Safi’s blood cell therapy products. FastPharming has the potential to be part of many such deals in the future. $IBIO conference is Today (there are speculation of possible contract or partnership)